Last updated: June 5, 2025
Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Overall Status: Active - Recruiting
Phase
N/A
Condition
Liver Disease
Primary Biliary Cholangitis
Treatment
Software Group
Clinical Study ID
NCT07007741
XH-25-001
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
NAFLD patient (CAP value >248 (dB/m))
Age 18-65 years old, 24kg/m2 ≤ BMI ≤ 35kg/m2
Must be able to use smartphone
Exclusion
Exclusion Criteria:
Inherited metabolic or autoimmune liver disease
Drug/toxic/alcoholic/biliary liver injury, cirrhosis or any end-stage liver disease
Hepatic or extrahepatic malignant tumours
Pregnant and lactating women
Patients considered ineligible by the investigator's clinical judgment
Study Design
Total Participants: 120
Treatment Group(s): 1
Primary Treatment: Software Group
Phase:
Study Start date:
October 26, 2023
Estimated Completion Date:
December 31, 2025
Connect with a study center
XinHua Hospital Affiliated To Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai 200082
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.